Back to home
A multicentre, double-blind, randomised, placebo - controlled phase II study to assess efficacy, safety and pharmacokinetics of inhaled Esketamine in subject with treatment-resistant depression in the courseof Major Depressive Disorder
Log in
e-mail
password
Log in
Forgot your password?
Reset password
×
Reset password
E-mail address